Literature DB >> 12814952

Comparative structure-function analysis of VEGFR-1 and VEGFR-2: What have we learned from chimeric systems?

Rosana D Meyer1, Nader Rahimi.   

Abstract

Activation of vascular endothelial growth factor receptor-1 and -2 (VEGFR-1 and VEGFR-2) plays a critical role in vasculogenesis and angiogenesis. However, the mechanism by which activation of VEGFRs elicits these cellular events is not fully understood. We recently constructed chimeric receptors containing the extracellular domain of human CSF-1R/c-fms fused with the entire transmembrane and cytoplasmic domains of murine VEGFR-1 and VEGFR-2. Selective activation of chimeric VEGFR-2, but not chimeric VEGFR-1, stimulated endothelial cell growth, migration, and differentiation. Stimulation of cells coexpressing chimeric VEGFR-1 and VEGFR-2 suppressed VEGFR-2-mediated endothelial cell growth. Site-directed mutagenesis demonstrated that tyrosines 799 and 1173 are required for VEGFR-2-mediated endothelial cell growth and activation of PI3 kinase. Further site-directed mutagenesis demonstrated that tyrosine 1212, located in the carboxyl tail of VEGFR-2, is required for the ligand-dependent autophosphorylation of the receptor and its ability to activate signaling proteins. Collectively, our results suggest that activation of VEGFR-1 and VEGFR-2 differentially regulates endothelial cell function and angiogenesis. Second, activation of VEGFR-2 is associated with many endothelial cell functions, including cell proliferation, migration, and differentiation. Third, activation of PI3 kinase by VEGFR-2 regulates endothelial cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12814952     DOI: 10.1111/j.1749-6632.2003.tb03223.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  18 in total

1.  Endothelial-derived hyperpolarization factor (EDHF) contributes to PlGF-induced dilation of mesenteric resistance arteries from pregnant rats.

Authors:  Maurizio Mandalà; Natalia Gokina; Carolyn Barron; George Osol
Journal:  J Vasc Res       Date:  2011-10-06       Impact factor: 1.934

Review 2.  VEGFR-1 and VEGFR-2: two non-identical twins with a unique physiognomy.

Authors:  Nader Rahimi
Journal:  Front Biosci       Date:  2006-01-01

3.  Oroxylin A inhibits angiogenesis through blocking vascular endothelial growth factor-induced KDR/Flk-1 phosphorylation.

Authors:  Ying Gao; Na Lu; Yun Ling; Yan Chen; Ling Wang; Qing Zhao; Qi Qi; Wei Liu; Haiwei Zhang; Qidong You; Qinglong Guo
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-04       Impact factor: 4.553

Review 4.  Vascular endothelial growth factor receptors: molecular mechanisms of activation and therapeutic potentials.

Authors:  Nader Rahimi
Journal:  Exp Eye Res       Date:  2006-05-19       Impact factor: 3.467

5.  Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways.

Authors:  Xiufeng Pang; Tingfang Yi; Zhengfang Yi; Sung Gook Cho; Weijing Qu; Decha Pinkaew; Ken Fujise; Mingyao Liu
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

6.  Roles of the endogenous VEGF receptors flt-1 and flk-1 in astroglial and vascular remodeling after brain injury.

Authors:  Janette M Krum; Nina Mani; Jeffrey M Rosenstein
Journal:  Exp Neurol       Date:  2008-04-03       Impact factor: 5.330

7.  Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases.

Authors:  D P Lesslie; J M Summy; N U Parikh; F Fan; J G Trevino; T K Sawyer; C A Metcalf; W C Shakespeare; D J Hicklin; L M Ellis; G E Gallick
Journal:  Br J Cancer       Date:  2006-06-05       Impact factor: 7.640

8.  The antihypertension drug doxazosin inhibits tumor growth and angiogenesis by decreasing VEGFR-2/Akt/mTOR signaling and VEGF and HIF-1α expression.

Authors:  Mi Sun Park; Boh-Ram Kim; Seung Myung Dong; Seung-Hoon Lee; Dae-Yong Kim; Seung Bae Rho
Journal:  Oncotarget       Date:  2014-07-15

9.  Effects of tetrahydrocurcumin on hypoxia-inducible factor-1α and vascular endothelial growth factor expression in cervical cancer cell-induced angiogenesis in nude mice.

Authors:  Bhornprom Yoysungnoen; Parvapan Bhattarakosol; Suthiluk Patumraj; Chatchawan Changtam
Journal:  Biomed Res Int       Date:  2015-02-18       Impact factor: 3.411

10.  Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2/PI3K/mTOR pathway in ovarian cancer xenografts.

Authors:  Mi Sun Park; Seung Myung Dong; Boh-Ram Kim; Seung Hee Seo; Sokbom Kang; Eun-Ju Lee; Seung-Hoon Lee; Seung Bae Rho
Journal:  Oncotarget       Date:  2014-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.